Notably, Hira depletion in Fh1-deficient cells controls the activation of an MYC- and E2F-dependent transcriptional and metabolic program, which is known to play different oncogenic roles during tumor initiation and progression (15, 16). The gene discussed is MYC; the disease is neoplasm.